← All indications
Common Variable Immunodeficiency
Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.
Drugs by status
Approved for this indication (1)
Phase 4 trials (1)
Phase 3 trials (1)
Phase 2 trials (19)
- 23-valent pneumococcal polysaccharide vaccine
- busulfan
- cd3,cd19 depleted hematopoietic stem cells
- tacrolimus
- lymphocyte immune globulin, anti-thymocyte globulin (equine)
- pentostatin
- pneumococcal 13-valent conjugate vaccine
- allogeneic hematopoietic stem cells
- sirolimus
- mycophenolate
- cyclophosphamide
- abatacept
- alemtuzumab
- mesna
- fludarabine
- thiotepa
- melphalan
- chloroprednisone
- fisetin
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (8)
Organization Involved with Other Experimental Indications (6)